SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

9480	Companies
185564	Keywords
117971	Articles
99400	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 06/09/2025 at 07:00, 5 months 26 days ago

Communiqué de presse : Sanofi accélère la livraison mondiale de Beyfortus pour préparer les professionnels de santé plusieurs mois avant la saison 2025-2026 de VRS
Sanofi accélère la livraison mondiale de Beyfortus pour anticiper la saison 2025-2026 de VRS. Durée de protection prolongée à six mois dans l'UE. Beyfortus : protection contre le VRS chez les nourrissons

Sanofi VRS Beyfortus Nourrissons Protection
BRIEF

published on 06/06/2025 at 20:27, 5 months 29 days ago

Sanofi annonce un rachat d'actions propres début juin 2025

Rachat D'actions Marché XPAR 2025 Sanofi Transaction Sur Actions
BRIEF

published on 06/06/2025 at 20:27, 5 months 29 days ago

Sanofi Discloses Repurchase of Own Shares in Early June 2025

Share Repurchase XPAR Market Stock Transaction 2025 Sanofi
PRESS RELEASE

published on 06/06/2025 at 20:22, 5 months 29 days ago

Sanofi : Déclaration des transactions sur actions propres
Sanofi déclare les transactions sur actions propres du 02 Juin 2025 au 06 Juin 2025 conformément à la réglementation. Présentation agrégée par jour et par marché

Actions Propres Transactions Réglementation Sanofi Présentation Agrégée
PRESS RELEASE

published on 06/06/2025 at 20:22, 5 months 29 days ago

Sanofi: Disclosure of trading in own shares
Sanofi discloses its trading in own shares from 02 June 2025 to 06 June 2025, repurchasing a total of 105,316 shares at an average price of 86.91 EUR per share on XPAR market

Trading Own Shares XPAR Repurchases Sanofi
BRIEF

published on 06/02/2025 at 07:05, 6 months 3 days ago

Sanofi va acquérir Blueprint Medicines pour 9,5 milliards de dollars

Maladies Rares Acquisition De Sanofi Médicaments Blueprint Pipeline D'immunologie Mastocytose Systémique
BRIEF

published on 06/02/2025 at 07:05, 6 months 3 days ago

Sanofi to Acquire Blueprint Medicines for $9.5 Billion

Rare Diseases Sanofi Acquisition Blueprint Medicines Immunology Pipeline Systemic Mastocytosis
PRESS RELEASE

published on 06/02/2025 at 07:00, 6 months 3 days ago

Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease. Acquisition includes Ayvakit/Ayvakyt for systemic mastocytosis and a promising pipeline in immunology

Acquisition Sanofi Rare Diseases Blueprint Medicines Immunological Disease
BRIEF

published on 05/30/2025 at 07:05, 6 months 6 days ago

L'itepekimab atteint son critère d'évaluation principal dans l'étude de phase 3 sur la BPCO

Sanofi BPCO Regeneron Itepekimab AERIFY-1
BRIEF

published on 05/30/2025 at 07:05, 6 months 6 days ago

Itepekimab Reaches Primary Endpoint in COPD Phase 3 Study

Sanofi COPD Regeneron Itepekimab AERIFY-1

Accesswire

Published on 12/06/2025 at 02:00, 2 hours 17 minutes ago

Northern Dynasty Provides Update on Board Search and Audit & Risk Committee Composition
Published on 12/06/2025 at 01:15, 3 hours 2 minutes ago

Prospect Ridge Announces Closing of Flow-Through Unit Private Placement
Published on 12/06/2025 at 00:25, 3 hours 52 minutes ago

GMV Minerals Announces Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Published on 12/06/2025 at 00:00, 4 hours 17 minutes ago

Bird River Announces Closing of $0.10 Common Share Financing
Published on 12/05/2025 at 23:30, 4 hours 47 minutes ago

55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 22:15, 6 hours 1 minute ago

CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 6 hours 5 minutes ago

EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 9 hours 19 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 9 hours 50 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 10 hours 1 minute ago

Completion of merger to form Helvetia Baloise Holding Ltd

Les Echos

Published on 12/05/2025 at 23:00, 5 hours 17 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 5 hours 17 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 5 hours 17 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 5 hours 17 minutes ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 10 hours 59 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible

View all LES ECHOS COMFI WIRE